Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
India
/
Healthcare
/
Poly Medicure
Create a narrative
Poly Medicure Community
BSE:531768 Community
3
Narratives
written by author
0
Comments
on narratives written by author
5
Fair Values set
on narratives written by author
Community Investing Ideas
Poly Medicure
Popular
Undervalued
Overvalued
Poly Medicure
AN
AnalystHighTarget
Community Contributor
Aging Populations And Medtech Trends Will Unlock Global Potential
Key Takeaways Pipeline of high-margin, innovative medical products and strategic partnerships position Poly Medicure for accelerated global growth and increased market share. Forward integration, capacity expansion, and automation initiatives are set to structurally improve cost control, profitability, and operational resilience.
View narrative
₹2.84k
FV
28.4% undervalued
intrinsic discount
19.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Poly Medicure
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Expanding Premium Medical Categories Will Unlock Global Opportunities
Key Takeaways Expansion into high-margin segments and proprietary device innovation is set to enhance revenue growth, operating leverage, and profitability as production scales. Tailwinds from India's healthcare policies, geographic diversification, and new international partnerships will drive above-industry growth and reduce regional dependence.
View narrative
₹2.28k
FV
10.7% undervalued
intrinsic discount
17.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
21 days ago
author updated this narrative
Poly Medicure
AN
AnalystLowTarget
Community Contributor
Rising Regulation And Trade Tensions Will Curb Exports Despite Upside
Key Takeaways Increased demand from demographic trends supports growth, but global cost pressures and regulatory risks threaten revenues and constrain pricing power, especially in export markets. Expansion into new products and geographies drives potential growth, yet rising costs, compliance pressures, and industry consolidation could compress margins and earnings.
View narrative
₹2.02k
FV
0.9% overvalued
intrinsic discount
17.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
22 days ago
author updated this narrative